Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Vitamin D  COVID-19 treatment studies for Vitamin D  C19 studies: Vitamin D  Vitamin D   Select treatmentSelect treatmentTreatmentsTreatments
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta
Lactoferrin Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
0 0.5 1 1.5 2+ Case 50% Improvement Relative Risk c19early.org/d Ribeiro et al. Vitamin D for COVID-19 Sufficiency Favors vitamin D Favors control
Previous vitamin D status and total cholesterol are associated with SARS-CoV-2 infection
Ribeiro et al., Clinica Chimica Acta, doi:10.1016/j.cca.2021.08.003
Ribeiro et al., Previous vitamin D status and total cholesterol are associated with SARS-CoV-2 infection, Clinica Chimica Acta, doi:10.1016/j.cca.2021.08.003
Aug 2021   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
Retrospective 1,634 patients tested for SARS-CoV-2 in Brazil, showing vitamin D levels <30ng/mL associated with greater odds of a positive SARS-CoV-2 test in patients older than 49 years.
risk of case, 50.5% lower, OR 0.50, p = 0.01, inverted to make OR<1 favor high D levels, >30ng/mL, multivariate, RR approximated with OR.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Ribeiro et al., 5 Aug 2021, retrospective, Brazil, peer-reviewed, 8 authors.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperVitamin DAll
Abstract: Clinica Chimica Acta 522 (2021) 8–13 Contents lists available at ScienceDirect Clinica Chimica Acta journal homepage: www.elsevier.com/locate/cca Previous vitamin D status and total cholesterol are associated with SARS-CoV-2 infection Heriks Gomes Ribeiro a, 1, Raquel Costa Silva Dantas-Komatsu b, 1, Jeane Franco Pires Medeiros b, Maria Clara da Cruz Carvalho a, Victor de Lima Soares c, Bruna Zavarize Reis d, e, *, André Ducati Luchessi a, b, Vivian Nogueira Silbiger a, e a Department of Clinical and Toxicological Analyses, Federal University of Rio Grande do Norte, Natal, RN, Brazil Postgraduate Program in Health Sciences, Federal University of Rio Grande do Norte, Natal, Brazil DNA Center Laboratory, Natal, Brazil d Department of Nutrition, Center for Health Sciences, Federal University of Rio Grande do Norte, Natal, Brazil e Postgraduate Program in Nutrition, Center for Health Sciences, Federal University of Rio Grande do Norte, Natal, Brazil b c A R T I C L E I N F O A B S T R A C T Keywords: COVID-19 Cholecalciferol Lipid Profile SARS-CoV-2 Background: The relationship of vitamin D status and other biochemical parameters with the risk of SARS-CoV-2 infection remains inconclusive, especially in regions with high solar incidence. Therefore, we aimed to associate the 25-hydroxyvitamin D (25(OH)D) concentrations and lipid profile prior to the SARS-CoV-2 tests in a popu­ lation from a sunny region in Brazil (5 degrees S, 35 degrees W). Methods: This retrospective cohort study enrolled 1634 patients tested for SARS-CoV-2 of a private medical laboratory with 25(OH)D concentration and lipid profile measured ≥ 7 days before the date of the first SARSCoV-2 RT-PCR test and were categorized according to 25(OH)D sufficiency (≥30 ng/mL) or insufficiency (<30 ng/mL). Multiple logistic regression analyses were performed to assess risk factors associated with positive tests for SARS-CoV-2. Results: Average serum 25(OH)D was 33.6 ng/mL. Vitamin D deficiency (<20 ng/mL) was only found in 2.6% of the participants. Multivariate analysis demonstrated that patients > 49 y with insufficient 25(OH)D (<30 ng/mL) presented increased odds to test positive for SARS-CoV-2 (OR: 2.02, 95 %CI: 1.15 to 3.55, P = 0.015). The same is observed among those with total cholesterol > 190 mg/dL (OR: 1.90, 95 %CI: 1.10 to 3.28, P = 0.020). Conclusions: Previous insufficient 25(OH)D (<30 ng/mL) concentration and high total cholesterol were associ­ ated with SARS-CoV-2 infection among adults > 48 y in the study population. Further studies should be con­ ducted to confirm whether measurement of 25(OH)D and lipid profile could be useful to identify patients who are more susceptible to COVID-19.
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit